Transcript of "Healthcare, Regulatory and Reimbursement Landscape - Turkey"
Healthcare, Regulatory and Reimbursement Landscape - TurkeyReport Details:Published:November 2012No. of Pages: 169Price: Single User License – US$1995Healthcare, Regulatory and Reimbursement Landscape - TurkeySummaryGlobalData, the industry analysis specialist, has released its latest report, “Healthcare, Regulatoryand Reimbursement Landscape - Turkey”. It is an essential source of information and analysis onTurkey’s healthcare, regulatory and reimbursement landscape. It identifies the key trends in thehealthcare market and provides insights into the demographic, regulatory and reimbursementlandscape and healthcare infrastructure. Most importantly, the report provides valuable insightsinto the trends and segmentation of the pharmaceutical and medical device markets. It is builtusing data and information sourced from proprietary databases, secondary research and in-houseanalysis by GlobalData’s team of industry experts.The population of Turkey has increased significantly over the years. In 2011, Turkey had apopulation of approximately 74 million. The overall population increased between 2006 and 2011from 69.4 to 74.0 million, mainly due to the increasing life expectancy. In 2011, Turkey was the17th most populated nation in the world. As is the case in most developed countries, the elderlypopulation is increasing and in 2012 comprises more than 10% of the population. The working agegroup contributes more than 50% of the total population and is expected to reach 56.3% of thetotal population by 2020, resulting in an increase in the available labor pool in the country.In 2010, the pharmaceutical market of Turkey was approximately $9.8 billion and Turkey was thesixth largest pharmaceutical market in Europe. The pharmaceutical market is to grow at aCompound Annual Growth Rate (CAGR) of 6.1% from 2005 to 2020, and is estimated to reach$21.6 billion in 2020.The market for medical devices in Turkey is large due to the increasing elderly population andsubsequent increase in the demand for healthcare products and services. The medical devicemarket in Turkey was valued at approximately $1.8 billion in 2006. It grew at a CAGR of 4.8% from2006 to 2011 and reached $2.2 billion in 2011. The market is predicted to reach to $3.3 billion by2020. Turkey predominantly depends on imports for the medical devices. Turkey has a largenumber of domestic producers also but these are involved with products which do not require high
technology.Scope- Overview of Turkey’s pharmaceutical and medical device markets, including size, segmentationand key drivers and barriers- Profiles and SWOT analyses of the major players in the pharmaceutical and medical devicemarkets. Key players in the pharmaceutical market are Abdi Ibrahim, Novartis, Sanofi, Bilim andPfizer. Key players in the medical devices market are Siemens Healthcare, Roche, Essilor,Fresenius and Baxter.- Insightful review of the reimbursement and regulatory landscape, comprising details of thehealthcare reimbursement process, regulatory agencies and approval processes for new drugsand medical devices- Detailed analysis of Turkey’s political and economic environment, including economic indicators,demographics, healthcare infrastructure and healthcare expenditure- An overview of the opportunities for and challenges to growth in the healthcare marketReasons to buyThis report comprehensively covers Turkey’s pharmaceutical and medical device markets and willenhance your decision-making capability by allowing you to -- Develop business strategies by understanding the trends shaping and driving Turkey’shealthcare market- Drive revenues by understanding key trends, reimbursement and regulatory policies,pharmaceutical and medical device market segments and companies likely to impact thehealthcare market in the future- Formulate effective sales and marketing strategies by understanding the competitive landscapeand analyzing the performance of various competitors- Organize your sales and marketing efforts by identifying the market categories and segmentsthat present the most opportunities for consolidation, investment and strategic partnerships- Identify, understand and capitalize on the opportunities and challenges in Turkey’s healthcaremarketGet your copy of this report @http://www.reportsnreports.com/reports/209355-healthcare-regulatory-and-reimbursement-landscape-turkey.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 51.1 List of Tables 71.2 List of Figures 92 Introduction 112.1 Report Guidance 11
3 Overview of Pharmaceutical and Medical Devices Markets 123.1 Pharmaceutical Market 123.1.1 Market Overview 123.1.2 Supply Channels 143.1.3 Market Segments 153.1.4 Major Therapeutic Areas 203.1.5 Major Players 223.2 Medical Device Market 473.2.1 Market Overview 473.2.2 Overview of Top Five Segments 493.2.3 Major Players 603.3 Market Drivers and Barriers 833.3.1 Market Drivers 833.3.2 Market Barriers 834 Market Access 854.1 Reimbursement and Payer Landscape 854.1.1 Overview of Healthcare System 854.1.2 Reimbursement Process 884.1.3 Overview of Insurance Providers 894.1.4 Patient Share in Healthcare Spending 904.1.5 Pricing Trends in Healthcare Industry 914.1.6 Pricing Policies 914.2 Regulatory Landscape 924.2.1 Overview of Regulatory Agencies 924.2.2 Drug Approval Process 924.2.3 New Device Approval Process 944.2.4 Licensing Process for Manufacturing 954.2.5 Licensing Process for Pharmaceutical Imports 964.2.6 Intellectual Property Rights Landscape 964.2.7 Clinical Trial Regulations 964.2.8 Pharmaceutical Advertising Regulations 974.2.9 Pharmacy Regulations 984.2.10 Labeling and Packing Regulations 995 Country Analysis 1005.1 Political Environment 1005.1.1 Political Structure 1005.1.2 Analysis of the Current Political Environment 1015.1.3 Healthcare Policy Initiatives 1025.2 Economic Landscape 1035.3 Economic Indicators 1045.3.1 Gross Domestic Product 1045.3.2 Gross National Income 106
5.3.3 Inflation 1075.3.4 Currency Exchange Rate 1105.3.5 Foreign Direct Investment 1115.3.6 Foreign Exchange Reserves 1125.3.7 Trade Balance 1135.3.8 Government Structural Balance 1155.3.9 Government Net Debt 1165.3.10 Major Industries 1175.4 Demographics 1185.4.1 Population 1185.4.2 Education and Literacy 1335.4.3 Employment 1365.4.4 Disease Burden 1385.5 Healthcare Infrastructure 1395.5.1 Healthcare Facilities 1395.5.2 Healthcare Parameters 1425.5.3 Environmental Health 1445.5.4 Healthcare Personnel 1485.6 Healthcare Expenditure 1515.6.1 Overview 1515.6.2 Health and Drug Expenditure 1535.6.3 Health Expenditure Per Capita 1555.6.4 Public and Private Sector Share 1565.6.5 Spending on Pharmaceutical R&D 1575.7 Trade Associations 1585.7.1 Turkish Pharmacists’ Association 1585.7.2 Pharmaceutical Manufacturer’s Association of Turkey 1585.7.3 Turkish Confederation of Employer Associations 1585.8 Trade Fairs 1596 Opportunities and Challenges 1606.1 Opportunities 1606.2 Challenges 1617 Appendix 1627.1 Abbreviations 1627.2 Bibliography 1637.3 Methodology 1677.3.1 Coverage 1677.3.2 Secondary Research 1677.3.3 Forecasting 1687.3.4 Primary Research 1687.3.5 Expert Panel Validation 1687.4 Contact Us 168